IVF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
INVO Fertility Inc (IVF) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown revenue growth and positive developments in expanding its fertility care network, the technical indicators are bearish, and the stock lacks immediate positive trading signals. Additionally, the financial performance still reflects significant losses, and there is no strong momentum or sentiment to suggest a compelling entry point right now.
The technical indicators suggest a bearish trend. The MACD is negatively expanding and below 0, the RSI is in the neutral zone at 27.639, and the moving averages indicate a bearish alignment (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 1.076, with key support at 0.948 and resistance at 1.204.
The acquisition of Family Beginnings Clinic for $760,000 is a positive development, as it expands INVO Fertility's network of fertility care centers. Revenue increased by 22.60% YoY in Q3 2025, and gross margin improved significantly by 87.56% YoY.
The stock price has been declining, with a -4.18% regular market change and bearish technical indicators. The company reported a net income loss of -$2,644,625 in Q3 2025, and EPS dropped significantly by -94.92% YoY. There are no significant insider or hedge fund trading trends, and no recent congress trading data is available.
In Q3 2025, revenue increased by 22.60% YoY to $1,757,094, and gross margin improved by 87.56% YoY to 28.04. However, the company remains unprofitable, with a net income loss of -$2,644,625, despite a 62.18% YoY improvement. EPS dropped significantly to -6.14, down -94.92% YoY.
Maxim recently upgraded INVO Fertility to 'Buy' from 'Hold' with a price target of $4, suggesting optimism for the stock's long-term potential.
